Summary E-cadherin (E-CD) is a calcium-dependent cell-cell adhesion molecule which is expressed in almost all epithelial tissues. E-CD expression is involved in epidermal morphogenesis and is reduced during tumour progression of mouse epidermal carcinogenesis. It has been suggested that E-CD could play a role as an invasion-suppressor molecule. In the present work we have studied the E-CD expression in 31 patients with basal cell carcinoma (BCC) using an immunohistochemical technique with a monoclonal antibody (HECD-1) specific for human E-CD. E-CD expression was preserved in all specimens of superficial and nodular BCC, and was reduced in 10 of 15 infiltrative BCCs. A heterogeneous distribution of cells with different immunostaining intensity was more frequently observed in specimens of infiltrative BCC. These results suggest that E-CD might be related to the growth pattern and the local aggressive behaviour of BCC, and support the idea that E-CD might play a role as an invasion-suppressor molecule in vivo.
Cadherins are calcium-dependent cell-cell adhesion transmembrane glycoproteins present on most cells. They mediate homophilic (like-with-like) adhesion between cells (Takeichi, 1991) . Cadherins play a crucial role during embryogenesis and morphogenesis, as well as in the maintenance of adult tissue architecture (Takeichi, 1991) . This family of adhesion molecules may be subdivided in two major groups, such as classic cadherins (including the first three characterised cadherins: epithelial type E-CD, neural type N-CD and placental type P-CD) and desmosomal cadherins. Classic cadherins are concentrated in the adherens type of intercellular junctions (Magee & Buxton, 1991) .
In normal mouse and human epidermis, at least two classical cadherins are expressed: E-CD and P-CD (Eidelman et al., 1989; Hirai et al., 1989; Shimoyama et al., 1989; Burge & Schomberg, 1992) . By indirect immunofluorescence or by immunohistochemical techniques E-CD is detected on the lateral and upper surfaces of basal keratinocytes (polarised form), and all around the periphery of keratinocytes in the spinous layer (non-polarised form), with a punctate linear pattern. It has been shown that E-CD plays an important role in epidermal morphogenesis (Hirai et al., 1989; Nicholson et al., 1991; Wheelock & Jensen, 1992) . On the other hand, E-CD expression is reduced during tumour progression of mouse epidermal carcinogenesis, suggesting that disturbances in E-CD-mediated cell-cell adhesion may be implicated in this process (Navarro et al., 1991; Ruggeri et al., 1992) . Furthermore, a possible role for E-CD as an invasionsuppressor molecule has been suggested (Behrens et al., 1989; Frixen et al., 1991; Vleminckx et al., 1991; Chen & Obrink, 1991) . Some cancer cell lines derived from poorly differentiated human carcinomas had lost E-CD expression and were invasive in collagen gels, whereas other highly differentiated cell lines in which E-CD was expressed were not invasive . In biopsy specimens of human carcinomas, E-CD is frequently reduced or absent in the most dedifferentiated tumours (Shimoyama & Hirohashi, 1991a,b; Shiozaki et al., 1991; Schipper et al., 1991; Oka et al., 1992 Oka et al., , 1993 ; Umbas et al., 1992; Van der Wurff et al., 1992; Inoue et al., 1992; Matsuura et al., 1992; Dorudi et al., 1993; Gamallo et al., 1993; Kinsella et al., 1993; Mayer et al., 1993; Terpe et al., 1993) . In addition, cell-cell adhesion and glandular differentiation of the human colon carcinoma cell line SW1222, which displays high levels of E-CD, was inhibited by a monoclonal antibody (HECD-1) specific for E-CD (Pignatelli et al., 1992) . Thus, all these observations suggest that E-CD plays some role in the genesis of histological differentiation and could be implicated in the acquisition of invasive potential of human cancer cells.
In this study, we report the distribution of E-CD in BCC of skin. This tumour is the most common cancer in humans.
Although BCC has a low metastatic potential, some cases show increased aggressiveness and tendency to recurrence after treatment, most frequently in infiltrative, morpheaform and metatypical (basosquamous) histological types (Miller, 1991) . Herein, we have examined E-CD expression by immunohistochemistry with the monoclonal antibody HECD-1 (Shimoyama et al., 1989) in three different histological types of BCC (superficial, nodular and infiltrative), which differ in both growth pattern and local invasiveness. E-CD expression in tumours has been compared with the distribution and intensity of E-CD immunostaining in normal human epidermis. (Shimoyama et al., 1989) was used. This monoclonal antibody was kindly provided by M. Takeichi (Kyoto University, Kyoto, Japan). (Navarro et al., 1991; Gamallo et al., 1993) . Briefly, cryostat sections of 5 -6 gm thickness were cut, air dried and fixed in acetone at 4°C. The slides were incubated with the MAb HECD-1 for 1 h at 37°C in a humidified chamber. The primary antibody was used at a dilution of 1:250, made in 150 mM sodium chloride, 10 mM HEPES pH 7.4, 10 mM calcium chloride (HMF-Ca buffer), containing 1% (w/v) bovine serum albumin (BSA). After washing in Tris buffer pH 7.4, with 1% BSA, sections were incubated with biotinylated goat anti-mouse IgG (Biomakor, Rehovot, Israel) diluted 1:200 for 30 min at 37°C, followed by a 30 min incubation with a 1:250 dilution of extravidin-alkaline phosphatase complex (Biomakor) at 37°C. Dilution of the secondary antibody was made in Tris buffer containing preimmune goat serum (1:50 dilution). Extravidin-alkaline phosphatase complex was diluted in Tris buffer-1% BSA. The alkaline phosphatase activity was developed using 2 mg of naphthol AS-MX phosphate (Sigma, St Louis, MO, USA) dissolved in 200 jil of dimethylformamide (Sigma), and mixed with 0.1 M Tris buffer pH 8.2, made up to 10 ml. To block endogenous alkaline phosphatase, 10 Il of a levamisole solution 1 M (Sigma) was added. The reaction was completed with 10 mg of fast red dye (Sigma) as the chromogen group. The sections were counterstained with Meyer haematoxylin and mounted for light microscopic study. Negative controls consisted of consecutive sections of each tumour in which the primary antibody was replaced with an irrelevant monoclonal antibody of the same species directed towards Aspergillus niger glucose oxidase (mouse IgG 1; Dako, Glostrup, Denmark).
Evaluation of the immunohistochemical staining All specimens were read blind by two experienced pathologists. The intensity of immunostaining in tumour cells was classified as (+ +) when as strong as the normal epidermis, (+) when weak and (-) when cells were not stained. 'Preserved E-CD expression' implied that more than 75% of the tumour cells were strongly (+ +) stained. 'Reduced expression' of E-CD implied that more than 25% of the tumour cells were positively stained but less than 75% of the tumour cells were strongly (+ +) stained. 'Severely reduced' E-CD expression implied that more than 75% of cells were not stained and 'absent E-CD expression' meant that E-CD staining was completely lost. In case of disagreement by the two pathologists, the slides were reviewed by a third pathologist who did not know the nature of the antigen being tested and the hypothesis under investigation. A consensus based on the two nearest opinions was obtained.
Statistical analysis
The chi-square test was used to analyse the statistical significance between E-CD expression and both histological pattern and sex. The Mann-Whitney U-test was used to evaluate the statistical significance between E-CD expression and both age and tumour size.
Results
Results are summarised in Tables I and II . E-CD was expressed with variable intensity in all specimens without exception and showed a punctate linear pattern around the periphery of tumour cells. The E-CD immunostaining of the outer cell layer of the tumour nests was occasionally positive on the cell surface in contact with the basement membrane zone (BMZ) (Figure lb, d and f) . On the contrary, E-CD was absent on the cell surface in contact with the BMZ in the basal keratinocytes of normal epidermis (Figure 1h ). E-CD expression was preserved in all specimens of superficial BCC (Figure la) , and was widely homogeneous in the tumour nests in six cases (Figure lb) . Reduced staining of the inner cell layers was seen in two cases.
Preserved expression of E-CD was also found in the eight .1 . *6. b Figure 1 Histopathology (a, c, e and g) and immunostaining for E-cadherin (b, d, f and h) in different histological types of basal cell carcinomas (BCCs) and normal epidermis. Superficial BCC (a) and nodular BCC (c), with, strong and homogeneous E-CD immunostaining (b and d). Infiltrative BCC (e), with reduced and heterogeneous E-CD immunostaining (f). Normal epidermis (g), with expression of E-CD in all the living layers (h). E-CD staining is stronger in the spinous layer than in the basal layer. Note that E-CD immunostaining is absent on the cell surface in contact with basement membrane zone (BMZ) in normal epidermis (h, arrows), whereas E-CD staining is positive on the cell surface in contact with BMZ in some tumour cells (b, d and f, arrowheads). nodular BCCs examined (Figure ic) . In three cases, particularly in the largest tumour nests, cells at the periphery were more strongly stained than those of the inner layer. E-CD expression was homogeneous throughout the tumour mass in the other five cases (Figure ld) .
Finally, 15 infiltrative BCCs were studied (Figure le) . Ten tumours showed reduced expression of E-CD. A homogeneous weak staining was found in two tumours, and a heterogeneous staining was found in eight tumours. Six of them showed a mixed population of weak and strong cells, and two tumours showed groups of negative cells intermingled with positive cells (Figure 1 f) . E-CD expression was preserved in the other five cases of infiltrative BCC, being homogeneous in two cases and heterogeneous in three.
Statistical analysis showed a significant association between reduction in E-cadherin expression and the infiltrative growth pattern (Table II) . No significant correlation was found between E-CD expression and age, sex or tumour size.
Discussion
One of the most characteristic features of human BCC of skin is the low metastatic potential of this neoplasm (Domarus & Stevens, 1984; Lo et al., 1991) . However, some tumours have elevated local invasiveness (Siegle et al., 1986; Leffel et al., 1991; Ko et al., 1992) . Although metastatic potential does not seem to be related to histological type of BCC, the local aggressive behaviour and the tendency to recurrence after therapy seem to be higher in morpheaform and infiltrative subtypes (Miller, 1991) .
In view of the fact that experimental studies suggest a role for E-CD as an invasion-suppressor molecule (Behrens et al., 1989; Frixen et al., 1991; Vleminckx et al., 1991; Chen & Obrink, 1992) , we considered of great interest the study of E-CD expression in different histological types of human BCC of skin. Our results showed preserved E-CD expression in all cases of superficial BCC. This histological type of BCC is characterised by tumour nests attached to the undersurface of the epidermis, with little penetration into the dermis. The peripheral cell layer of the nests often shows a welldemarcated palisading (Lever & Schaumburg-Lever, 1990 ). We also found preserved E-CD expression in nodular BCC, which is characterised by masses of various shapes and sizes embedded in the dermis. Tumour nests of nodular BCC have a rounded smooth outline and well-developed palisading (Lever & Schaumburg-Lever, 1990) . In contrast to the former histological types of BCC, E-CD expression was reduced in most cases (10 of 15) of infiltrative BCC. The growth pattern of infiltrative BCC is characterised by the presence of small cell nests and aggregates with spiky irregular configuration and poorly developed peripheral palisading, as well as cords and strands of tumour cells extending from the basal layer of the epidermis into the deep dermis (Siegle et al., 1986) . These results suggest that reduced E-CD expression may be related to the infiltrative growth pattern. On the other hand, we have not observed a significant association between E-CD expression and age, sex or tumour size. We have not performed statistical analysis of the correlation between E-CD expression and anatomical site because of the diversity in the location of the tumour included in this short series (Table I) . Further studies on a large scale are needed to clarify this question.
With regard to the pattern of E-CD expression in these tumours, we have observed a heterogeneous distribution in a few cases of superficial and nodular BCC. In these cases, E-CD expression was typically strong at the periphery of the tumour nests and weak in the inner cell layers. In contrast E-CD expression was heterogeneous in most cases of infiltrative BCC, with intermingled populations of cells of different immunostaining intensity. Thus, we can speculate that a more homogeneous and stable E-CD expression among cells in contact may favour the superficial and nodular growth pattern, whereas a more heterogeneous and unstable E-CD expression may favour the infiltrative growth pattern. Many other observations also support the idea that tumours of heterogeneous composition may have increased invasive potential (Hashimoto et al., 1989; Mareel et al., 1991; Bussemakers et al., 1992 : Umbas et al., 1992 . Thus, our results strongly suggest that E-CD expression is related to the growth pattern and the local invasiveness of BCC. Furthermore, many other studies also support the idea that E-CD is involved in the growth pattern of epithelial neoplasms in humans. For example, E-CD tends to be preserved in gastric carcinomas and ductal breast carcinomas with an expansive growth pattern, and impaired in those with an infiltrative growth pattern (Oka et al., 1992 (Oka et al., , 1993 . In the same way, E-CD is absent in almost all cases of lobular breast carcinoma, a tumour characterised by a diffuse infiltrating pattern of small cells extending in single lines between collagen bundles (Gamallo et al., 1993; Rasbridge et al., 1993) . All these studies support the view that E-CD may be one of the multiple biological factors involved in the growth pattern, local invasiveness and metastatic potential of human carcinomas (Van Roy & Mareel, 1992; Aznavoorian et al., 1993) .
The apparently contradictory observation of preserved E-CD expression in a few cases of infiltrative BCC may be explained, at least in part, by the existence of some putative mechanisms that interfere with cadherin function in cancer cells, or that could overcome the invasive-suppressor function of E-CD operating in the E-CD-positive carcinomas Shimoyama et al., 1992; Behrens et al., 1993) . However, despite their common aggressive growth pattern, not all infiltrative BCCs have the same tumorigenicity and local aggressive behaviour. Thus, further studies are needed to investigate the possible role for E-CD in reducing tumorigenicity and invasiveness in those infiltrative BCCs with preserved E-CD expression, as well as the functional status of E-CD in these tumours. On the other hand, increased expression of other cell adhesion molecules in BCC, such as the integrin receptors VLA-2 and VLA-3 (Stamp & Pignatelli, 1991) , may also contribute to the pattern of growth and the clinical behaviour of BCC.
Finally, we have observed E-CD expression on the cell surface in contact with the basement membrane zone in some tumour cells, whereas E-CD is absent in this surface of basal cells in normal human epidermis. This phenomenon was observed in all studied histological types of BCC. We do not know the biological significance, if any, of this observation. However, the expression of E-CD on the cell surface in contact with the extracellular matrix may be a consequence of the loss of cell polarity that is usually found during epithelial oncogenesis (Schoenenberger & Matlin, 1991) .
In summary, the observations made in this study suggest that E-CD expression may contribute to the growth pattern and the local aggressive behaviour of BCC. These results further support the idea that E-CD might play a role as an invasion-suppressor molecule in vivo.
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